Hua Medicine, Chunlai Education kick off HK flotations
Biotechnology firm Hua Medicine has launched bookbuilding for its Hong Kong IPO, targeting up to HK$972.1m ($123.9m) in proceeds.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: